Prognostic and therapeutic implications of EGFR and KRAS mutations in resected lung adenocarcinoma.

Marks JL, Broderick S, Zhou Q, Chitale D, Li AR, Zakowski MF, Kris MG, Rusch VW, Azzoli CG, Seshan VE, Ladanyi M, Pao W
J Thorac Oncol. 2008 3 (2): 111-6

PMID: 18303429 · DOI:10.1097/JTO.0b013e318160c607

MeSH Terms (17)

Adenocarcinoma Adult Aged Aged, 80 and over Chemotherapy, Adjuvant Drug Resistance, Neoplasm ErbB Receptors Female Genes, ras Humans Lung Neoplasms Male Middle Aged Mutation Prognosis Protein Kinase Inhibitors Survival Analysis

Connections (1)

This publication is referenced by other Labnodes entities: